1COLE S P C, BHANDWAJ G, GERLACH J H, et al. Overexpression of a transporter gene in a multidrug-resistance human lung cancer cell llne [J]. Science, 1992,258(4) : 1640-1654.
2ENDO K, MAEHARA Y, KUSUMOTO T, et al. Expression of muhidrug-resistance-assoeiated protein (MRP) and chemsensitivity in human gastric cancer[J]. Int J Cancer, 1996,68(4) : 372-377.
3TAKEBAYASHI Y, AKIYAMA S, NATSUGOE S, et al. The expression of multidrug, resistance protein in human gastrointestinal tract carcinoma[J]. Cancer, 2D02,86(4) : 661-666.
4SAKAMOTO H, YONEZAWA S, UTSUNOMIYA T, et al. Mutin antigen expression in gastric carcinomas of young and old adults [J]. Hum Pathd, 1997,28(9) : 1056-1065.
5SCHEPER R J, BROXTERMAN H J, SCHETTER G L, et al, Overexpression of a Mr 110,000 vesicular protein in non-P-glycoprotein-mediated multidrug resistance[J]. Cancer Res, 1993, 53 (7) : 1475-1479.
6SCHEFFER G L, WIJINGARD P L G, FLENS M J, et al. The drug resistance-related protein (LRP) is the vault protein[J]. Nature Med, 1995,1(6): 578-582.
7IKEDA K, OKAM, NARASAKI F, et al. Lung resistance-related protein gene expression and drug sensitivity in human gastric and lung cancer cells[J]. Anticancer Res, 2003,23(40) : 3077-3080.
8KUNZE N, YAANG G C, DOLBERG M, et al. Structure of the human type Ⅰ DNA topoisomerase gene [J]. J Biol Chem, 1991,266(15): 9610-9616.
9SON Y S, SUH J M, AHN S H, et al. Reduced activity of topoisomeraae Ⅱ in an Adriamycin-resistance human stomach-adenocarcinoma cell line[J]. Cancer Chemother Pharmacol, 1998,41(5) :353-360.
10KELLNER U, HUTCHINSON L, SEIDEL A, et al. Decreased drug accumulation in a mitoxantrone-resistant gastric carcinoma cell line in the absence of P-glycoprotein[J]. Int J Cancer, 2001,75 (5) : 817-824.
